COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $507,000 | -65.9% | 52,800 | -74.3% | 0.00% | -50.0% |
Q2 2022 | $1,488,000 | -29.8% | 205,500 | +25.2% | 0.00% | 0.0% |
Q1 2022 | $2,119,000 | +137.8% | 164,100 | +194.1% | 0.00% | +100.0% |
Q4 2021 | $891,000 | -73.6% | 55,800 | -75.8% | 0.00% | -75.0% |
Q1 2021 | $3,371,000 | -25.7% | 230,700 | -11.7% | 0.00% | -20.0% |
Q4 2020 | $4,540,000 | +202.3% | 261,200 | +218.9% | 0.01% | +400.0% |
Q3 2020 | $1,502,000 | -79.3% | 81,900 | -79.8% | 0.00% | -83.3% |
Q2 2020 | $7,253,000 | +459.6% | 406,100 | +408.3% | 0.01% | +500.0% |
Q1 2020 | $1,296,000 | -43.8% | 79,900 | -37.6% | 0.00% | -50.0% |
Q4 2019 | $2,305,000 | +717.4% | 128,000 | +648.5% | 0.00% | – |
Q3 2018 | $282,000 | -10.2% | 17,100 | -21.9% | 0.00% | – |
Q2 2017 | $314,000 | -86.9% | 21,900 | -80.7% | 0.00% | -100.0% |
Q1 2017 | $2,394,000 | +50.0% | 113,200 | +19.8% | 0.00% | 0.0% |
Q2 2016 | $1,596,000 | -6.8% | 94,500 | +10.5% | 0.00% | -25.0% |
Q3 2015 | $1,713,000 | +44.9% | 85,500 | +109.0% | 0.00% | +33.3% |
Q2 2015 | $1,182,000 | – | 40,907 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |